Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Feb;50(2):107-9.
doi: 10.1007/BF00298784.

Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy

Affiliations

Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy

S Fatemi et al. Calcif Tissue Int. 1992 Feb.

Abstract

Hypercalcemia of malignancy is a commonly encountered serious clinical problem that often requires aggressive therapy. In order to combine the rapid hypocalcemic effects of calcitonin with the more delayed effect of a bisphosphonate, we administered etidronate, 7.5 mg/kg/day intravenously and salmon calcitonin, 100 IU subcutaneously, every 12 hours for 3 days in 9 patients with hypercalcemia associated with malignancy. The mean serum calcium concentration fell from 3.33 +/- 0.1 mmol/liter (mean +/- SEM) to 2.88 +/- 0.1 mmol/liter within 24 hours (P less than 0.001). All patients had a fall in the serum calcium concentration of greater than 0.5 mmol/liter and it returned to normal in 7 of the 9 patients. We conclude that the combination of salmon calcitonin with etidronate more effectively lowers the serum calcium concentration in patients with hypercalcemia of malignancy then the use of either agent alone.

PubMed Disclaimer

Comment in

References

    1. Am J Med. 1987 Feb 23;82(2A):42-50 - PubMed
    1. Lancet. 1989 Nov 18;2(8673):1180-2 - PubMed
    1. Calcif Tissue Int. 1990;46 Suppl:S26-30 - PubMed
    1. Q J Med. 1981 Autumn;50(200):473-81 - PubMed
    1. J Clin Invest. 1986 Aug;78(2):355-60 - PubMed